Cirmaker Technology Corp. is an investment holding company. The company is headquartered in Cathedral City, California. The company went IPO on 2002-11-29. The company is primarily focused on Distressed Asset Restructuring, Residential Development Projects, and Venture Capital and Innovation Pipeline. In Distressed Asset Restructuring, the Company acquires high-potential assets burdened by financial inefficiencies and implements tailored restructuring strategies, including leaseback mechanisms and conditional buybacks. Its residential platform provides housing solutions and is executing an approximately 1,000-unit development program targeting middle-income markets. The company also invests capital in ventures in real estate technology, modular construction, and financial infrastructure. Its subsidiary is Beagalltach Holdings Limited. Beagalltach Holdings Limited owns over 50.2% of Moralltach Global Plc., which is a distressed property purchaser and developer located in Ireland.
根據最新的財務報表(Form-10K),Blackrock Health Sciences Trust 的總資產為 $0,淨損失為 $0
CRKT 的關鍵財務比率是什麼?
Blackrock Health Sciences Trust 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Cirmaker Technology Corp 的收入按細分市場或地理位置如何劃分?
Blackrock Health Sciences Trust 最大收入來源為 Program of All-inclusive Care for the Elderly,在最近的收益報告中收入為 852,709,000。就地區而言,United States 是 Blackrock Health Sciences Trust 的主要市場,收入為 853,699,000。
Cirmaker Technology Corp 是否盈利?
無,根據最新的財務報表,Blackrock Health Sciences Trust 的淨損失為 $0